Endocrinol Metab.  2024 Apr;39(2):397-398. 10.3803/EnM.2024.202.

Multiple Definitions of Fatty Liver Disease: Which One Most Accurately Predicts Diabetes?

• Rhee EJ

• KMID: 2554644
• DOI: http://doi.org/10.3803/EnM.2024.202

Reference

1. Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020; 73:202–9.

2. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2024; 29:101133.

3. Bae JC. No more NAFLD: the term is now MASLD. Endocrinol Metab (Seoul). 2024; 39:92–4.

4. Rhee EJ. Nonalcoholic fatty liver disease and diabetes: an epidemiological perspective. Endocrinol Metab (Seoul). 2019; 34:226–33.

5. Chung SM, Kang MK, Moon JS, Park JG. Performance of simple fibrosis score in non-alcoholic fatty liver disease with and without type 2 diabetes. Endocrinol Metab (Seoul). 2023; 38:277–81.